Skip to main content

Peer Review reports

From: Preclinical and clinical phase I studies of a new recombinant Filgrastim (BK0023) in comparison with Neupogen®

Original Submission
24 Jul 2013 Submitted Original manuscript
12 Sep 2013 Author responded Author comments - Davide Crobu
Resubmission - Version 2
12 Sep 2013 Submitted Manuscript version 2
2 Dec 2013 Reviewed Reviewer Report - Pedro Gascon
23 Dec 2013 Reviewed Reviewer Report - Jonathan Hoggatt
21 Jan 2014 Author responded Author comments - Davide Crobu
Resubmission - Version 3
21 Jan 2014 Submitted Manuscript version 3
Publishing
1 Feb 2014 Editorially accepted
21 Feb 2014 Article published 10.1186/2050-6511-15-7

You can find further information about peer review here.

Back to article page